| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Sep'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total revenue | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 867 | 717 | - | - | - | - | - | - |
License and collaboration revenue | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 324 | - | - | - | - | - |
Total revenue | |||||||||||||||||
1,213 | 1,379 | 1,316 | 1,101 | 1,100 | 4,036 | 648 | 649 | 658 | - | - | - | 324 | - | - | - | - | - |
Operating expenses: | |||||||||||||||||
Research and development | |||||||||||||||||
4,916 | 5,558 | 8,598 | 6,189 | 4,827 | 4,837 | 5,697 | 6,176 | 6,335 | 6,111 | 5,193 | 6,962 | 6,946 | 9,128 | 14,988 | 14,468 | 7,905 | 3,177 |
General and administrative | |||||||||||||||||
2,507 | 1,817 | 2,290 | 3,311 | 2,994 | 2,712 | 3,295 | 2,620 | 2,880 | 2,459 | 2,762 | 3,361 | 4,531 | 4,010 | 2,493 | 3,467 | 3,367 | 2,449 |
Total operating expenses | |||||||||||||||||
7,423 | 7,375 | 10,888 | 9,500 | 7,821 | 7,549 | 8,992 | 8,796 | 9,215 | 8,570 | 7,955 | 10,323 | 11,477 | 13,138 | 17,481 | 17,935 | 11,272 | 5,626 |
Operating loss | |||||||||||||||||
-6,210 | -5,996 | -9,572 | -8,399 | -6,721 | -3,513 | -8,344 | -8,147 | -8,557 | -7,832 | -7,088 | -9,606 | -11,153 | -13,138 | -17,481 | -17,935 | -11,272 | -5,626 |
Other income, net: | |||||||||||||||||
Interest income | |||||||||||||||||
35 | 28 | 53 | 68 | 28 | 55 | 83 | 115 | 44 | 9 | 22 | 29 | 27 | - | - | - | - | - |
Interest expense | |||||||||||||||||
- | 1 | 0 | 1 | 0 | 262 | 262 | 261 | 262 | 262 | 262 | 262 | 262 | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - | - | - |
Other income, net | |||||||||||||||||
8 | 21 | 23 | 36 | 56 | 40 | 28 | 4 | 0 | 13 | 1 | 0 | 5 | - | - | - | - | 30 |
Total other income, net | |||||||||||||||||
43 | 48 | 76 | 103 | 84 | -167 | -151 | -142 | -218 | -240 | -239 | -233 | -230 | 77 | 7 | 31 | 12 | - |
Loss from continuing operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -5,596 |
Loss from discontinued operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -480 |
Net Income (Loss) Attributable to Parent | |||||||||||||||||
-6,167 | -5,948 | -9,496 | -8,296 | -6,637 | -3,680 | -8,495 | -8,289 | -8,775 | -8,072 | -7,327 | -9,839 | -11,383 | -13,061 | -17,474 | -17,904 | -11,260 | -6,076 |
Comprehensive loss | |||||||||||||||||
-6,167 | -5,948 | -9,496 | -8,296 | -6,637 | -3,680 | -8,495 | -8,289 | -8,775 | - | -7,327 | - | - | - | - | - | - | - |
Continuing operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.45 |
Discontinued operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.21 |
Net loss per share, basic and diluted (in USD per share) | |||||||||||||||||
-0.17 | -0.22 | -0.36 | -0.32 | -0.25 | -0.14 | -0.33 | -0.32 | -0.35 | -0.50 | -0.46 | -0.62 | -0.71 | 7.70 | -5.76 | -7.31 | -4.60 | -2.66 |
Weighted-average common shares outstanding, basic and diluted (in shares) | |||||||||||||||||
37,043 | 26,685 | 26,189 | 26,069 | 26,066 | 26,056 | 26,046 | 26,039 | 25,026 | 15,997 | 15,984 | 15,975 | 15,967 | 16,015 | 3,033 | 2,448 | 2,445 | 2,281 |
License and collaboration revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
1,024 | 1,176 | 1,100 | 1,101 | 1,100 | 4,036 | 648 | 649 | 649 | - | - | - | - | - | - | - | - | - |
Research and development services revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
- | - | - | - | - | 0 | 0 | 0 | 9 | - | - | - | - | - | - | - | - | - |
Government research contracts and grants revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
189 | 203 | 216 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - |